BMY Stock — Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. (BMY)

BMY is a low-cost Stock. As of August 28, 2026, its distribution rate is 3.76%, its trailing-12-month yield is 3.77%. Dividend Vision Distribution Safety Score™ is 100/100 (Safe). Its deepest 1-year drawdown was 12.5%.

At the current 3.76% distribution rate, a $10,000 investment would generate approximately $376 per year, or $31.33 per month on an equivalent basis. Actual quarterly payments vary.

Bristol-Myers Squibb is a biopharmaceutical company that discovers, develops, and commercializes drugs across oncology, hematology, immunology, cardiovascular, and neuroscience indications, with major products including Opdivo for cancer, Eliquis for stroke prevention and blood clots, Revlimid for multiple myeloma, and Orencia for rheumatoid arthritis. The company pays a quarterly distribution with a current yield in the mid-single digits. Bristol-Myers Squibb appeals to income-focused investors seeking exposure to large-cap pharmaceutical companies with established dividend histories.

BMY performance

Data as of August 28, 2026.

Its deepest 1-year drawdown was 12.5%.

BMY key facts

Data as of August 28, 2026.

Distribution Safety Score™

100 · Safe

Safety-Adjusted Yield

3.76%

Asset type

Stock

Asset class

Equity

Inception date

06/01/1972

Distribution rate

3.76%

Distribution frequency

Quarterly

Trailing yield

3.77%

5-year average yield

3.96

Last close

$66.58

Market cap

$138,026,221,568

Average volume

5542352.0

Last dividend

$0.6300

Ex-dividend date

07/02/2026

Payment date

08/03/2026

Beta

0.225

Payout ratio

0.3856

P/E ratio

14.8833

Forward P/E

9.8425

EPS

$4.54

How Dividend Vision calculates yield and returns

Distribution rate (3.76%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (3.77%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 28, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of August 28, 2026.

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BMY risks and drawbacks

BMY's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 12.5%.

Who may consider BMY — and who may not

BMY may suit someone looking for low-cost broad dividend exposure, a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (BMY pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Frequently asked questions